Maravai LifeSciences Holdings, Inc. MRVI Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$184.29M+20.1% | -$230.76M-7.9% | -$213.81M+37.3% | -$341.21M-17.7% | -$289.8M-11.6% | ||
| $22.77M-3.4% | $23.56M+2.0% | $23.09M+4.2% | $22.16M+1.8% | $21.76M+4.3% | ||
| $26.51M-12.1% | $30.17M-18.0% | $36.79M-9.8% | $40.79M-14.6% | $47.76M-3.3% | ||
| $72.77M-14.0% | $84.6M+54.2% | $54.85M-73.8% | $209.08M+17.0% | $178.64M+7.5% | ||
| —— | —— | —— | —— | —— | ||
| -$7.58M+5.2% | -$8M-49.3% | -$5.36M-122% | -$2.41M-40,100% | -$6K+98.4% | ||
| -$477K+93.5% | -$7.35M-1,841% | $422K-53.5% | $908K-75.4% | $3.7M+411% | ||
| -$11.8M-155% | -$4.63M-163% | $7.32M+54.1% | $4.75M— | —— | ||
| -$818K+49.7% | -$1.63M-26.2% | -$1.29M-94.9% | -$661K— | —— | ||
| -$10.34M+44.5% | -$18.63M-4.2% | -$17.89M-10.9% | -$16.13M-18.0% | -$13.66M-117% | ||
| —— | —— | —— | —— | —— | ||
| $27.39M-2.0% | $27.95M-1.4% | $28.34M+1.1% | $28.02M+1.2% | $27.69M+0.6% | ||
| $8.38M-6.5% | $8.96M+1.5% | $8.83M+1.8% | $8.68M+1.2% | $8.57M+1.0% | ||
| -$39.52M+31.4% | -$57.57M— | —— | —— | —— | ||
| $13.09M-0.5% | $13.15M-22.1% | $16.88M-25.1% | $22.55M-20.9% | $28.49M-3.9% | ||
| —— | —— | —— | $18.99M+1.9% | $18.63M— | ||
| —— | $0-100% | $450K-50.0% | $900K-33.3% | $1.35M-25.0% | ||
| -$12.71M+59.5% | -$31.41M+8.2% | -$34.22M+15.0% | -$40.26M+6.8% | -$43.2M-77.7% | ||
| $55.44M+919% | $5.44M-97.7% | $234.39M0.0% | $234.39M0.0% | $234.39M0.0% | ||
| —— | —— | —— | —— | —— | ||
| -$66.83M-305% | -$16.5M+93.4% | -$250.87M-3.7% | -$241.81M-0.6% | -$240.28M-1.8% | ||
| —— | —— | -$46K-21.1% | -$38K-152% | $73K— | ||
| -$119.13M-12.9% | -$105.51M+68.5% | -$334.58M-10.3% | -$303.26M-5.3% | -$288.12M-9.1% | ||
| $24.6M-1.5% | $24.98M-26.3% | $33.88M-14.5% | $39.6M-12.7% | $45.35M-11.0% | ||
| -$700K-24.8% | -$561K-4.9% | -$535K-121% | -$242K-140% | $612K-8.7% | ||
| $27.39M-2.0% | $27.95M-1.4% | $28.34M+1.1% | $28.02M+1.2% | $27.69M+0.6% | ||
| —— | —— | —— | —— | $137.05M-17.5% | ||
| $22.77M-3.4% | $23.56M+2.0% | $23.09M+4.2% | $22.16M+1.8% | $21.76M+4.3% | ||
| -$10.34M+44.5% | -$18.63M-4.2% | -$17.89M-10.9% | -$16.13M-18.0% | -$13.66M-117% | ||
| —— | -$181K-4.0% | -$174K-4.2% | -$167K-4.4% | -$160K-4.6% | ||
| -$818K+49.7% | -$1.63M-26.2% | -$1.29M-94.9% | -$661K— | —— | ||
| $8.38M-6.5% | $8.96M+1.5% | $8.83M+1.8% | $8.68M+1.2% | $8.57M+1.0% | ||
| —— | —— | —— | —— | —— | ||
| —— | $0-100% | $450K-50.0% | $900K-33.3% | $1.35M-25.0% | ||
| —— | -$10K-109% | $116K-52.1% | $242K-34.2% | $368K-25.5% | ||
| —— | $0-100% | $1.78M-50.0% | $3.55M-33.3% | $5.33M-25.0% | ||
| —— | —— | —— | —— | -$4.86M-176% | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | $4.8M— | ||
| —— | —— | —— | —— | —— | ||
| -$700K-24.8% | -$561K-4.9% | -$535K-121% | -$242K-140% | $612K-8.7% | ||
| -$52.6M+25.6% | -$70.72M-6.6% | -$66.33M— | —— | —— | ||
| -$52.6M+25.6% | -$70.72M-6.6% | -$66.33M— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Maravai LifeSciences Holdings, Inc. generate?
- Maravai LifeSciences Holdings, Inc. (MRVI) generated -$39.5M in operating cash flow over the trailing twelve months.
- What is Maravai LifeSciences Holdings, Inc.'s free cash flow?
- After $13.1M of capital expenditures, Maravai LifeSciences Holdings, Inc.'s free cash flow was -$52.6M over the trailing twelve months, down 283.3% year over year.
- Where does Maravai LifeSciences Holdings, Inc.'s cash flow data come from?
- Every line is extracted from Maravai LifeSciences Holdings, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
